VERONA PHARMA PLC - ADR (VRNA) Stock Income Statement
NASDAQ:VRNA - Nasdaq - US9250501064 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 42.28M | 0.00 | 460.00K | 40.00M | 0.00 | |||
| Cost Of Goods | 2.58M | 0.00 | 350.00K | N/A | N/A | |||
| Gross Profit | 39.70M | 0.00 | 110.00K | N/A | N/A | |||
| Operating Expenses | 194.32M | 67.57M | 75.85M | 113.31M | 74.28M | |||
| Research and Development | 44.57M | 17.22M | 49.28M | 79.41M | 44.51M | |||
| Selling, General, and Administrative Expenses | 149.75M | 50.35M | 26.58M | 33.91M | 29.77M | |||
| Operating Income | -154.63M | -67.57M | -75.75M | -73.31M | -74.28M | |||
| Interest Income/Expense | -8.45M | 12.57M | -1.52M | 2.10M | 1.01M | |||
| Other Income/Expense | 3.60M | 1.10M | 9.63M | 15.63M | 8.27M | |||
| Non Recurring Items | -3.65M | 0.00 | -820.00K | N/A | N/A | |||
| Income Before Taxes | -163.13M | -53.90M | -68.45M | -55.59M | -65.00M | |||
| Income Tax | 10.29M | 474.00K | 250.00K | -20.00K | 150.00K | |||
| Net Income | -173.42M | -54.37M | -68.70M | -55.57M | -65.15M | |||
| EBITDA | -153.57M | -66.89M | -75.11M | -72.68M | -73.66M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.07 | -0.67 | -1.01 | -0.94 | -1.95 | |||
| Non GAAP EPS | -2.16 | -0.68 | -1.11 | -0.97 | -2.47 | |||
| Statistics | ||||||||
| Gross Profit Margin | 93.89% | N/A | 23.91% | N/A | N/A | |||
| Profit Margin | -410.18% | N/A | -14934.78% | -138.93% | N/A | |||
| Operating Profit Margin | -365.73% | N/A | -16467.39% | -183.28% | N/A | |||
All data in USD